These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2191994)

  • 1. Carrier detection of the X-linked primary immunodeficiency diseases using X-chromosome inactivation analysis.
    Winkelstein JA; Fearon E
    J Allergy Clin Immunol; 1990 Jun; 85(6):1090-7. PubMed ID: 2191994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal diagnosis and genetic analysis of X-linked immunodeficiency disorders.
    Puck JM
    Pediatr Res; 1993 Jan; 33(1 Suppl):S29-33; discussion S33-4. PubMed ID: 8433872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier detection in X-linked immunodeficiencies. II: An X inactivation assay based on differential methylation of a line-1 repeat at the DXS255 locus.
    Hinds H; Craig IW; Chen ZY; Kraakman ME; Schuurman RK; Hendriks RW
    Immunodeficiency; 1993; 4(1-4):213-5. PubMed ID: 8167703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X chromosome linked immunodeficiency.
    Schwaber J; Rosen FS
    Immunodefic Rev; 1990; 2(3):233-51. PubMed ID: 1981831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrier detection in typical and atypical X-linked agammaglobulinemia.
    Conley ME; Puck JM
    J Pediatr; 1988 May; 112(5):688-94. PubMed ID: 2896233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency.
    Conley ME; Lavoie A; Briggs C; Brown P; Guerra C; Puck JM
    Proc Natl Acad Sci U S A; 1988 May; 85(9):3090-4. PubMed ID: 2896355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrier detection in X-linked immunodeficiencies. I: A PCR-based X chromosome inactivation assay at the MAOA locus.
    Hendriks RW; Chen ZY; Hinds H; Schuurman RK; Craig IW
    Immunodeficiency; 1993; 4(1-4):209-11. PubMed ID: 8167702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A PCR based X-chromosome inactivation assay for carrier detection in X-linked immunodeficiencies using differential methylation of the androgen receptor gene.
    Schmucker B; Meindl A; Achatz H; Mittermüller J; Krüger G; Hergersberg M; Spiegel R; Schinzel A; Belohradsky BH; Murken J
    Immunodeficiency; 1995; 5(3):187-92. PubMed ID: 7749438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular approaches to analysis of X-linked immunodeficiencies.
    Conley ME
    Annu Rev Immunol; 1992; 10():215-38. PubMed ID: 1590986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of X chromosome inactivation analysis to establish carrier status for X-linked severe combined immunodeficiency.
    Goodship J; Malcolm S; Lau YL; Pembrey ME; Levinsky RJ
    Lancet; 1988 Apr; 1(8588):729-32. PubMed ID: 2895261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carrier detection in Wiskott-Aldrich syndrome: combined use of M27 beta for X-inactivation studies and as a linked probe.
    Goodship J; Carter J; Espanol T; Boyd Y; Malcolm S; Levinsky RJ
    Blood; 1991 Jun; 77(12):2677-81. PubMed ID: 2043768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carrier identification in X-linked immunodeficiency diseases.
    Li SL; Ting SS; Lindeman R; Ffrench R; Ziegler JB
    J Paediatr Child Health; 1998 Jun; 34(3):273-9. PubMed ID: 9633977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of human X-linked immunodeficiency diseases.
    Hendriks RW; Schuurman RK
    Clin Exp Immunol; 1991 Aug; 85(2):182-92. PubMed ID: 1863997
    [No Abstract]   [Full Text] [Related]  

  • 14. Carrier detection in X-linked severe combined immunodeficiency based on patterns of X chromosome inactivation.
    Puck JM; Nussbaum RL; Conley ME
    J Clin Invest; 1987 May; 79(5):1395-400. PubMed ID: 2883199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trisomy X in a female member of a family with X linked severe combined immunodeficiency: implications for carrier diagnosis.
    Lester T; de Alwis M; Clark PA; Jones AM; Katz F; Levinsky RJ; Kinnon C
    J Med Genet; 1994 Sep; 31(9):717-20. PubMed ID: 7815443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linkage of PGK1 to X-linked severe combined immunodeficiency (IMD4) allows predictive testing in families with no surviving male.
    Goodship J; Levinsky R; Malcolm S
    Hum Genet; 1989 Dec; 84(1):11-4. PubMed ID: 2606471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X chromosome inactivation patterns in haematopoietic cells of female carriers of X-linked severe combined immunodeficiency determined by methylation analysis at the hypervariable DXS255 locus.
    Hendriks RW; Kraakman ME; Schuurman RK
    Clin Genet; 1992 Sep; 42(3):114-21. PubMed ID: 1395081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular genetics of X-linked primary immunodeficiencies: advances in diagnosis and prevention].
    Carbonara A; Brusco A; Carbonara C
    Ann Ital Med Int; 1996; 11(3):180-6. PubMed ID: 8998263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-linked severe combined immunodeficiency: localization within the region Xq13.1-q21.1 by linkage and deletion analysis.
    Puck JM; Nussbaum RL; Smead DL; Conley ME
    Am J Hum Genet; 1989 May; 44(5):724-30. PubMed ID: 2565084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular genetic diagnosis of Wiskott-Aldrich syndrome].
    Orth U; Rosenkranz W; Schwinger E; Holzgreve W; Gal A
    Monatsschr Kinderheilkd; 1993 Sep; 141(9):728-31. PubMed ID: 8413349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.